RVNC…was on my list to buy today, but my timing couldn’t be worse. …given results and your previous bullishness, do you still think [it’s] significantly undervalued at current level?
I think RVNC is still a solid buy for the long-term; they are now almost assured to launch a best-in-class product in a fast-growing market in the next two years or so.
As I’m typing, RVNC’s enterprise value on a fully-diluted basis is about $1.1B (#msg-135963594, #msg-135963545). I previously estimated that AGN’s Botox franchise had a net present value of $24B (#msg-127654469), so there is plainly a lot of headroom here.
However, if you are looking for merely a trade, you might do better to wait for RVNC to raise capital, which they are almost certain to do in the next few months.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.